A compound developed by researchers at the R. Ken Coit College of Pharmacy moves one step closer to commercialization with licensing agreement.
A study conducted by researchers at the University of Arizona Health Sciences and the University of Illinois found that viral loads of the SARS-CoV-2 virus can be reduced by small molecule PLpro inhibitors.Continue reading